Sikiri P, Seiwerth S, Grabarevi Z, Rucman R, Petek M, Jagi V, et al
Day 2 backed Epitalon and Semax but rejected Emideltide The FDA peptide vote 2026 ended with six favorable peptide-level recommendations and one unfavorable recommendation
Individual response: Some researchers respond dramatically to IGF-1 peptides while others notice minimal effects
Injectable NAD+ As interest in NAD+ therapy continues to grow, both oral and injectable forms are now commonly used for supplementation
When you look upstream, ingredient suppliers often think the same way, too. For example, Lucree saw similar proliferation within collagen as an ingredient in years past
JUMPSTART YOUR WELLNESS FROM WITHIN